Corrigendum to the newspaper publication dated February 14, 2026, regarding unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals had published its unaudited financial results (both consolidated and standalone) for the quarter and nine months ended December 31, 2025 in newspapers on February 14, 2026. Certain typographical errors were later found in the Kannada-language version of that advertisement. To correct this, the company published a corrigendum on February 15, 2026 in the same Kannada newspaper, Hosa Digantha, with the necessary corrections. The company has confirmed that all other details in the original advertisement remain unchanged and that the corrigendum should be read together with the original publication.
This is a routine administrative correction with no change to the actual financial results. There is no material impact on shareholders or the stock price — the underlying Q3 FY26 numbers stand as originally disclosed.